ERD

E-learning platform for patients and caregivers

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Results dissemination campaign

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Manuscript on metanalysis of the effectiveness of T cell therapy after different lymphodepleting/conditioning regimens

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Systematic review and manuscript on the landscape of preclinical safety testing

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Standards technical committee

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Landscape of HCP information available

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Regulatory advice on model development

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Data management plan

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Roadmap for addressing unmet needs and gaps in preclinical efficacy tools and models

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

List of proposed standards to be developed, manuscript

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Roadmap for addressing unmet needs and gaps

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Publication Policy

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Regulatory advice

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Working group for patients and Caregivers

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

RRI Charter

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Project Charter

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Concept dissemination campaign

Project: T2EVOLVE

Updated at: 02-09-2024

Show more information

Project acronym T2EVOLVE

Periodic Reporting for period 2 - T2EVOLVE (Accelerating Development and Improving Access to CAR and TCR-engineered T ce...

Project: T2EVOLVE

Updated at: 29-04-2024

Show more information

Project acronym T2EVOLVE

Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute...

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft ...

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Development of optimal lymphodepletion/conditioning regimens – Work Package 6 of the T2EVOLVE Project

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Time to evolve: predicting engineered T cell-associated toxicity with next-generation models

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Upscaled CART-cells targeting IL-1RAP produced in a closed semi-automatic system, in GMP-like conditions, are ready for ...

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leuke...

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Targeting metabolic rewiring might decrease spread of tumor cells: Mitochondrial tRNA modifications promote cancer metas...

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

CAR Density Influences Antitumoral Efficacy of BCMA CAR T cells and Correlates with Clinical Outcome

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple pr...

Project: T2EVOLVE

Updated at: 31-01-2024

Show more information

Project acronym T2EVOLVE

Resources

Selected filters:

E-learning platform for patients and caregivers

Results dissemination campaign

Manuscript on metanalysis of the effectiveness of T cell therapy after different lymphodepleting/conditioning regimens

Systematic review and manuscript on the landscape of preclinical safety testing

Standards technical committee

Landscape of HCP information available

Regulatory advice on model development

Data management plan

Roadmap for addressing unmet needs and gaps in preclinical efficacy tools and models

List of proposed standards to be developed, manuscript

Roadmap for addressing unmet needs and gaps

Publication Policy

Regulatory advice

Working group for patients and Caregivers

RRI Charter

Project Charter

Concept dissemination campaign

Periodic Reporting for period 2 - T2EVOLVE (Accelerating Development and Improving Access to CAR and TCR-engineered T ce...

Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute...

Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft ...

Development of optimal lymphodepletion/conditioning regimens – Work Package 6 of the T2EVOLVE Project

Time to evolve: predicting engineered T cell-associated toxicity with next-generation models

Upscaled CART-cells targeting IL-1RAP produced in a closed semi-automatic system, in GMP-like conditions, are ready for ...

Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leuke...

Targeting metabolic rewiring might decrease spread of tumor cells: Mitochondrial tRNA modifications promote cancer metas...

CAR Density Influences Antitumoral Efficacy of BCMA CAR T cells and Correlates with Clinical Outcome

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple pr...